Intra-operative application of chlorhexidine gel reduces bacterial counts in internal implant cavity

A single application of chlorhexidine gel reduces gingival inflammation and interleukin 1-β following one-stage implant placement: A randomized controlled study

BACKGROUND

Chlorhexidine (CHX) is a broad-spectrum antimicrobial agent commonly used in medicine. Application of (CHX) during abutment connection reduced the bacterial load at the implant-abutment interface. We hypothesize this treatment may consequently reduce peri-implant soft tissue inflammation and marginal bone loss.

PURPOSE

To evaluate the effect of a single application of CHX gel inside the dental implant internal hexagon on peri-implant tissue.

METHODS

Forty patients were recruited to this randomized, double-blinded, clinical trial. At the time of implant installation, a 4-mm healing abutment was connected to the implant. In the test group, chlorhexidine gel 1% was applied inside the implant hex, whereas control implants did not receive any gel. Clinical and radiographic measurements included soft tissue recession (REC), plaque index (PI), gingival index (GI), plaque index (PI), keratinized mucosa width (KM), probing depth (PD), and a peri-apical parallel x-ray. Peri-implant crevicular fluid (PICF) was collected for cytokine analysis. t-Test was used to compare changes from baseline to 3 months. Mann-Whitney U test and t test were used to compare test and control groups.

RESULTS

Twenty patients in the test group and 17 in the control group completed the study. One implant in the control group failed to osteointegrate. There were no significant differences between the control and test groups for REC changes, bone loss, and PD. GI was significantly lower in the test group after 1 week (1.79 ± 0.24 vs 0.75 ± 0.18, respectively) and 3 months (1.18 ± 0.21 vs 0.25 ± 0.12, respectively) although PI was equal. At 3 months, interleukin 1-β (IL1-β) was higher in the control group (p < 0.01) and a positive correlation was found between GI and IL1-β (r_s  = 0.60424, p = 0.00032).

CONCLUSIONS

Application of chlorhexidine gel reduced inflammation and IL1-β levels in the peri-implant soft tissue.

Influence of different agents on the preload force of implant abutment screws

STATEMENT OF PROBLEM

Screw loosening is a common problem in implant dentistry; however, information is sparse on the influence of different fluids on the screw threads.

PURPOSE

The purpose of this in vitro study was to investigate the influence of 4 different fluids and agents (saliva, blood, chlorhexidine [CHX] gel, and special sealing silicone) on the preload force of abutment screws.

MATERIALS AND METHODS

The test specimens (N=50) consisted of a thread sleeve resembling the implant, an abutment analog, and an abutment screw. The tightening of the screw with a torque wrench was performed in 5 steps (15 Ncm, 20 Ncm, 25 Ncm, 30 Ncm, and 35 Ncm). Each agent was applied in the lumen of the thread sleeve of 10 specimens. Ten dry thread sleeves served as the control. Comparisons between 2 independent groups were performed with the t test or Wilcoxon-Mann-Whitney test, as appropriate. The Bonferroni correction was used for multiple comparisons (α=.05).

RESULTS

Preload forces increased linearly with the applied tightening torque for dry implant lumina, as well as for saliva, blood, silicone, and CHX gel in the implant lumina or thread sleeves. In general, none of the tested agents resulted in significantly higher preload forces compared with the dry control.

CONCLUSIONS

The agents investigated did not have any lubricant action on implant abutment screws.

Bacterial Leakage at Implant-Abutment Interface With Different Intermediate Materials

A gap exists at the implant-abutment interface in two-piece implants and can serve as a reservoir of bacteria and compromise the health of peri-implant tissue. This study aimed to compare the effect of different intermediate materials on bacterial leakage at the implant-abutment interface. A total of 75 implants were divided into 5 groups (n = 15) based on the material applied at the implant-abutment connection: (1) Atridox, (2) chlorhexidine, (3) Gapseal silicone, (4) saliva, and (5) no material. All the implants were inoculated with 0.1 μL of Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) suspension, and then the respective material was applied. The abutments were connected to the implants, and appropriate torque was applied as recommended by the manufacturer (Implantium, Dentium, Korea, Seoul). Bacterial leakage was determined by evaluating the turbidity of the broth. Bacterial contamination was found in all samples at different times; in groups 1, 2 and 3, contamination was noted after 7, 5, and 6 days, respectively, on average. Contamination occurred averagely after 4 days in groups 4 and 5. The present study showed that Atridox applied at the implant-abutment interface significantly delayed bacterial leakage.